AlphaCentric Advisors LLC - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 43 filers reported holding VIRACTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
AlphaCentric Advisors LLC ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$329,000
-55.6%
90,000
-2.6%
0.10%
-48.9%
Q3 2021$741,000
-29.3%
92,4020.0%0.19%
-34.0%
Q2 2021$1,048,000
+22.6%
92,4020.0%0.28%
-1.0%
Q1 2021$855,00092,4020.29%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 288,571$1,232,0000.82%
Samsara BioCapital, LLC 689,709$2,945,0000.69%
BVF INC/IL 3,614,662$15,435,0000.64%
Rubric Capital Management LP 994,801$4,248,0000.21%
HAMILTON LANE ADVISORS LLC 35,791$153,0000.06%
MAI Capital Management 637,641$2,723,0000.05%
Jasper Ridge Partners, L.P. 92,939$397,0000.03%
BOURGEON CAPITAL MANAGEMENT LLC 20,500$88,0000.02%
Ergoteles LLC 132,636$566,0000.02%
Laurion Capital Management LP 698,000$2,980,0000.02%
View complete list of VIRACTA THERAPEUTICS INC shareholders